PHOENIX BIOINFORMATICS CORPORATION

Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,360,935
Investments
44%
Property, Plant, & Equipment (net)
34%
Cash & Equivalents
18%
Receivables (Non-Related)
4%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$1,031,360
Deferred Revenue
66%
Payables & Accruals
23%
Other Liabilities
11%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$455,024
$415,490
-9%
Receivables (Non-Related)
$142,522
$95,004
-33%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$27,336
$12,709
-54%
Investments
$914,651
$1,045,180
+14%
Property, Plant, & Equipment (net)
$618,879
$792,552
+28%
Other Assets
-
-
-
Total Assets
$2,158,412
$2,360,935
+9%
Liabilities
2023
2024
Change
Payables & Accruals
$206,729
$238,158
+15%
Grants Payable
-
-
-
Deferred Revenue
$609,827
$682,520
+12%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$110,336
$110,682
+0%
Total Liabilities
$926,892
$1,031,360
+11%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$1,231,520
$1,329,575
+8%
Net assets
2023
2024
Change
Net assets
+$1,231,520
+$1,329,575
+8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)